Chew SL - Search Results

1

Pseudoexon activation as a novel mechanism for disease resulting in atypical growth-hormone insensitivity.

Metherell LA, Akker SA, Munroe PB, Rose SJ, Caulfield M, Savage MO, Chew SL, Clark AJ. Metherell LA, et al. Among authors: chew sl. Am J Hum Genet. 2001 Sep;69(3):641-6. doi: 10.1086/323266. Epub 2001 Jul 20. Am J Hum Genet. 2001. PMID: 11468686 Free PMC article.

2

Putting some spine into alternative splicing.

Khoo B, Akker SA, Chew SL. Khoo B, et al. Among authors: chew sl. Trends Biotechnol. 2003 Aug;21(8):328-30. doi: 10.1016/S0167-7799(03)00168-9. Trends Biotechnol. 2003. PMID: 12902166

3

Pre-spliceosomal binding of U1 small nuclear ribonucleoprotein (RNP) and heterogenous nuclear RNP E1 is associated with suppression of a growth hormone receptor pseudoexon.

Akker SA, Misra S, Aslam S, Morgan EL, Smith PJ, Khoo B, Chew SL. Akker SA, et al. Among authors: chew sl. Mol Endocrinol. 2007 Oct;21(10):2529-40. doi: 10.1210/me.2007-0038. Epub 2007 Jul 10. Mol Endocrinol. 2007. PMID: 17622584 Free article.

4

Nuclear post-transcriptional control of gene expression.

Akker SA, Smith PJ, Chew SL. Akker SA, et al. Among authors: chew sl. J Mol Endocrinol. 2001 Oct;27(2):123-31. doi: 10.1677/jme.0.0270123. J Mol Endocrinol. 2001. PMID: 11564598 Review.

5

An alternatively spliced human insulin-like growth factor-I transcript with hepatic tissue expression that diverts away from the mitogenic IBE1 peptide.

Chew SL, Lavender P, Clark AJ, Ross RJ. Chew SL, et al. Endocrinology. 1995 May;136(5):1939-44. doi: 10.1210/endo.136.5.7720641. Endocrinology. 1995. PMID: 7720641

6

Clinical Use of Cinacalcet in MEN1 Hyperparathyroidism.

Moyes VJ, Monson JP, Chew SL, Akker SA. Moyes VJ, et al. Among authors: chew sl. Int J Endocrinol. 2010;2010:906163. doi: 10.1155/2010/906163. Epub 2010 May 26. Int J Endocrinol. 2010. PMID: 20585352 Free PMC article.

7

Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families.

Igreja S, Chahal HS, King P, Bolger GB, Srirangalingam U, Guasti L, Chapple JP, Trivellin G, Gueorguiev M, Guegan K, Stals K, Khoo B, Kumar AV, Ellard S, Grossman AB, Korbonits M; International FIPA Consortium. Igreja S, et al. Hum Mutat. 2010 Aug;31(8):950-60. doi: 10.1002/humu.21292. Hum Mutat. 2010. PMID: 20506337 Free PMC article.

8

Screening children at risk of developing inherited endocrine neoplasia syndromes.

Johnston LB, Chew SL, Trainer PJ, Reznek R, Grossman AB, Besser GM, Monson JP, Savage MO. Johnston LB, et al. Among authors: chew sl. Clin Endocrinol (Oxf). 2000 Feb;52(2):127-36. doi: 10.1046/j.1365-2265.2000.00956.x. Clin Endocrinol (Oxf). 2000. PMID: 10671936 Review. No abstract available.

9

Optimal dosage interval for depot somatostatin analogue therapy in acromegaly requires individual titration.

Jenkins PJ, Akker S, Chew SL, Besser GM, Monson JP, Grossman AB. Jenkins PJ, et al. Among authors: chew sl. Clin Endocrinol (Oxf). 2000 Dec;53(6):719-24. doi: 10.1046/j.1365-2265.2000.01168.x. Clin Endocrinol (Oxf). 2000. PMID: 11155094 Clinical Trial.

10

Investigating familial endocrine neoplasia syndromes in children.

Johnston LB, Chew SL, Lowe D, Reznek R, Monson JP, Savage MO. Johnston LB, et al. Among authors: chew sl. Horm Res. 2001;55 Suppl 1:31-5. doi: 10.1159/000063460. Horm Res. 2001. PMID: 11408759 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

129 results

Search Page